MUTUAL BENEFIT, ADDED VALUE?

Catherine M. Will

Journal of Cultural Economy, 2011, vol. 4, issue 1, 11-26

Abstract: The National Health Service (NHS) has recently been the focus of government efforts to retain pharmaceutical research in the UK. Efforts to foster new partnerships between healthcare providers and industry have been framed with suggestions that clinical trials can offer 'patient benefit' within the NHS, cutting across ethical and sociological concerns with the possible tension between doing research and offering care. This paper draws on ethnographic research to explore the sometimes awkward juxtapositions between trial protocols and everyday care, individual health and commercial profit, and thus the distribution of value produced through trials. While researchers appear to find the distinction between research and care useful, at least some of the time, both formal and informal strategies for living with this distinction may have the unintended consequence of making research appear supplementary to rather than simply different from clinical care.

Date: 2011
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1080/17530350.2011.535332 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:jculte:v:4:y:2011:i:1:p:11-26

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RJCE20

DOI: 10.1080/17530350.2011.535332

Access Statistics for this article

Journal of Cultural Economy is currently edited by Michael Pryke, Joe Deville, Tony Bennett, Liz McFall and Melinda Cooper

More articles in Journal of Cultural Economy from Taylor & Francis Journals
Bibliographic data for series maintained by ().